Biocon

Shaw informed about it through a tweet and said, “Mild symptoms and I hope it stays that way”

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics

The company's Research Services business reported flat revenue growth at Rs 422 Crore due to slowdown of operations impacted by…

"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by…

A multi-centric, open label, two-arm randomized pivotal clinical trial was conducted in 30 eligible patients at four hospitals…

Itolizumab is the first novel biologic therapy to be approved anywhere in the world for treating patients with moderate to severe…

FDA approval marks a significant milestone to help increase access and affordability of insulin for the millions of Americans…

She is the first woman entrepreneur from India and third Indian to win this title in WEOY Award’s 20-year History

Zydus Cadila, Cadila Pharma, Biocon, Syngene, Glenmark, Serum Institute of India, Ipca, Strides are using LSSSDC’s programmes to…

Reportedly, the PTAB also found Sanofi’s proposed amended claims for the ‘486 and ‘844 patents unpatentable.